Versor Investments LP Nevro Corp Transaction History

Versor Investments LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$18.22 - $25.85 $37,351 - $52,992	2,050 Added 22.86%	11,017 $211,000
Q2 2023 Aug 07, 2023	SELL	$22.62 - $39.32 $205,140 - $356,593	-9,069 Reduced 50.28%	8,967 $227,000
Q1 2023 May 05, 2023	BUY	$30.17 - $41.11 $221,327 - $301,582	7,336 Added 68.56%	18,036 $652,000
Q4 2022 Jan 30, 2023	BUY	$36.43 - $49.4 $389,801 - $528,580	10,700 New	10,700 $423,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.